Randomised double-blind phase 3 clinical study testing impact of atorvastatin on prostate cancer progression after initiation of androgen deprivation therapy: study protocol

Introduction Blood cholesterol is likely a risk factor for prostate cancer prognosis and use of statins is associated with lowered risk of prostate cancer recurrence and progression. Furthermore, use of statins has been associated with prolonged time before development of castration resistance (CR)...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Terho Lehtimäki, Antti Rannikko, Mikkel Fode, Michael Borre, Teuvo Tammela, Aino Siltari, Peter Østergren, Mika Helminen, Timo Marttila, Otto Ettala, Heikki Seikkula, Peter Boström, Jarno Riikonen, Juha Koskimäki, Tomi Pakarainen, Andres Kotsar, Paavo V Raittinen, Arto Salonen, Hanna Ronkainen, Sven Löffeler, Teemu J Murtola
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMJ Publishing Group 2022-04-01
coleção:	BMJ Open
Acesso em linha:	https://bmjopen.bmj.com/content/12/4/e050264.full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!